SKVI — SKINVISIBLE, INC.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1085277 ·
Last close
$0.18
Market Cap
$972.7K
52W High
$0.54
52W Low
$0.15
ADV30
258
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 5,000 | 5,000 | -125,938 | -267,184 | 119,419 | 1,798 | 10,649,384 |
| Dec 2025 | 5,000 | 5,000 | -114,169 | -258,357 | 127,567 | 2,620 | 10,390,348 |
| Sep 2025 | 5,000 | 5,000 | -106,057 | -250,245 | 133,623 | 645 | 10,138,047 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,512
Investing CF
$-4,086
Financing CF
$0
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.20
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-41,277,360
Inventory
—
Receivables
$22,592
ST Investments
—
EBIT TTM
$-477,871
Pretax Income TTM
$-1,050,213
Interest Exp TTM
$572,342
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$20,000
EBITDA
$-438,742
Free Cash Flow
$275,283
Enterprise Value
$6,945,136
Total Cash
$3,959
Total Debt
$5,862,923
Shares Out
5,403,843
Trailing EPS
$-0.20
Book Value
$-2.00
ROE
—
ROA
-215.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 20,000 | -496,315 | -1,064,034 | 127,567 | 10,390,348 | -10,262,781 | -38,410 |
| Dec 2024 | 20,000 | -589,589 | -565,654 | 158,217 | 9,381,744 | -9,223,527 | -69,834 |
| Dec 2023 | 20,000 | -490,375 | -2,382,440 | 162,869 | 9,185,912 | -9,023,043 | -77,157 |
| Dec 2022 | 279,296 | -238,432 | -1,224,887 | 246,793 | 6,887,396 | -6,640,603 | 45,170 |
TTM Snapshot
Revenues TTM
$20,000
NetIncome TTM
$-1,031,319
OpCashFlow TTM
—
Assets (Latest)
$123,334
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| OGEN | ORAGENICS INC | $947.5K | $0.21 | — |
| ATXI | AVENUE THERAPEUTICS, INC. | $922.6K | $0.28 | — |
| GOVX | GeoVax Labs, Inc. | $1.09M | $2.01 | — |
| APVO | Aptevo Therapeutics Inc. | $834.5K | $0.46 | — |
| PTIX | Protagenic Therapeutics, Inc.\new | $814.6K | $0.45 | — |
Recent Insider Activity
No insider activity indexed for this ticker.